Popular Penny Stocks to Add to Your Watchlist Right Now | FinancialContent Business Page
FinancialContent fully hosted finance channel
Stay updated with breaking news from Ribosome Modulating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FinancialContent fully hosted finance channel
May 27, 2021 Complements ELX-02 program in Phase 2 Clinical Trials for the Treatment of Cystic Fibrosis WALTHAM, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced that the Company has received an award of up to $2.6M from the Cystic Fibrosis Foundation.This award will help to identify optimized oral RMAs for further development in the treatment of cystic fibrosis (CF) patients with nonsense mutations. 'We are honored to receive this funding from theCystic...